Shane Cox
Acute Care · Anniston, ALNPI 1780264226
Payments from drug & device makers
Across 232 payments — averaging $17.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$568
- Ardelyx, Inc.$369
- AbbVie$352
- Merck$277
- Novartis$253
- Madrigal Pharmaceuticals$232
- plus $2K from 27 others
What the payments were for
- Food & beverage$3,99698%
- Education$842%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 26 | $568 |
| Ardelyx, Inc. | 22 | $369 |
| AbbVie | 26 | $352 |
| Merck | 16 | $277 |
| Novartis | 15 | $253 |
| Madrigal Pharmaceuticals | 15 | $232 |
| Phathom Pharmaceuticals, Inc. | 17 | $224 |
| QOL Medical, LLC | 8 | $207 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 13 | $175 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $143 |
| Aimmune Therapeutics, Inc. | 9 | $135 |
| Pfizer | 6 | $109 |
| Impulse Dynamics (USA) Inc. | 3 | $106 |
| Ipsen Biopharmaceuticals, Inc | 4 | $103 |
| AstraZeneca | 6 | $98 |
| Sanofi | 4 | $89 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $82 |
| Philips North America LLC | 5 | $79 |
| Bayer | 3 | $62 |
| Gilead | 3 | $54 |
| Evoke Pharma, Inc. | 2 | $44 |
| Ironwood Pharmaceuticals, Inc | 2 | $39 |
| Silk Road Medical, Inc. | 1 | $34 |
| Vifor Pharma, Inc. | 2 | $31 |
| Pacira Pharmaceuticals Incorporated | 1 | $30 |
| Electromed, Inc. | 1 | $28 |
| Boehringer Ingelheim | 2 | $28 |
| E.r. Squibb & Sons, L.L.C. | 1 | $26 |
| Esperion Therapeutics, Inc. | 2 | $26 |
| Novo Nordisk | 1 | $22 |
| Cvrx, Inc. | 1 | $21 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $18 |
| Angiodynamics, Inc. | 1 | $16 |
How this compares
$4,080 in reported general payments places this provider in the 85th percentile of 711 acute care providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 150 | $108,732 |
| EntrestoSacubitril/Valsartan | 118 | $89,083 |
| XareltoRivaroxaban | 32 | $31,963 |
| BrilintaTicagrelor | 27 | $15,186 |
| Atorvastatin Calcium | 159 | $1,779 |
| Losartan Potassium | 134 | $1,693 |
| Amlodipine Besylate | 237 | $1,634 |
| Metoprolol Succinate | 127 | $1,613 |
| Carvedilol | 201 | $1,341 |
| Lisinopril | 133 | $1,157 |
| ClopidogrelClopidogrel Bisulfate | 74 | $776 |
| Amiodarone Hcl | 50 | $674 |
| Digoxin | 27 | $650 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 33 | $615 |
| Ranolazine ErRanolazine | 11 | $555 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $109 | $108,732150 claims |
| NovartisEntresto | $253 | $89,083118 claims |
| Johnson & JohnsonXarelto | $568 | $31,96332 claims |
| AstraZenecaBrilinta | $98 | $15,18627 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 711 acute care providers in Alabama.
Other acute care in Anniston
- Shane WilliamonAnniston$7K
- Paige HarrisMontgomery$465K
- Coretta CollinsBirmingham$77K
- Debra DavisFoley$31K
- Leslie GastonMobile$22K
- Gwendolyn HooperTuscaloosa$16K
- Rachel PrytulaDothan$14K
- Jennifer UmbargerMobile$14K
- April KlarHuntsville$13K
- Cameron StephensonBirmingham$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.